申请人:Ciba-Geigy Corporation
公开号:US04595535A1
公开(公告)日:1986-06-17
Described are 5-diazacycloalkyltriazolo[2,3-c][1,3]benzodiazepines, for example compounds of the formula ##STR1## wherein R.sub.1 represents hydrogen, halogen, trifluoromethyl, lower alkylthio, lower alkoxy or lower alkyl; R.sub.2 represents hydrogen, lower alkyl or hydroxy-C.sub.2 -C.sub.7 alkyl wherein the hydroxy group is separated from the nitrogen atom by at least 2 carbon atoms; R.sub.3 represents hydrogen, lower alkyl, lower alkoxy, lower alkylthio, halogen or trifluoromethyl; and C.sub.n H.sub.2n represents ethylene. The synthesis, pharmaceutical compositions and methods of use as neuroleptic and/or antihistaminic agents are given.
本文描述了5-二氮杂环己基三唑并[2,3-c][1,3]苯二氮平类化合物,例如式中的化合物:##STR1## 其中R.sub.1代表氢、卤素、三氟甲基、较低的烷基硫、较低的烷氧基或较低的烷基;R.sub.2代表氢、较低的烷基或羟基-C.sub.2-C.sub.7烷基,其中羟基与氮原子至少相隔2个碳原子;R.sub.3代表氢、较低的烷基、较低的烷氧基、较低的烷基硫、卤素或三氟甲基;C.sub.n H.sub.2n代表乙烯基。给出了制备方法、制药组合物和作为神经精神药和/或抗组胺药使用的方法。